Irbesartan inhibits advanced glycation end product-induced increase in asymmetric dimethylarginine level in mesangial cells through its anti-oxidative properties

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2014-10, Vol.176 (3), p.1120-1122
Main Authors: Ishibashi, Yuji, Matsui, Takanori, Ueda, Seiji, Fukami, Kei, Okuda, Seiya, Yamagishi, Sho-ichi
Format: Article
Language:English
Subjects:
ADMA
AGEs
Antioxidants - pharmacology
Arginine - analogs & derivatives
Arginine - antagonists & inhibitors
Arginine - biosynthesis
Biphenyl Compounds - pharmacology
Cardiovascular
Cells, Cultured
DDAH
Glycation End Products, Advanced - antagonists & inhibitors
Glycation End Products, Advanced - metabolism
Humans
Irbesartan
Mesangial Cells - drug effects
Mesangial Cells - metabolism
Oxidative stress
RAGE
Tetrazoles - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2014.07.299